Association of stress hyperglycemia and atrial fibrillation in myocardial infarction

Koraćević, Goran; Petrović, Sladjana; Damjanović, Miodrag; Stanojlovic, Teodora

doi:10.1007/s00508-008-0983-8

Cited by 27 publications

(14 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the present study, an APG >140 mg/dL (7.8 mmol/L) was defined as admission hyperglycemia in accordance with the 2013 ADA Standard of Medical Care criteria 15, which were determined based on a number of large scale studies of the effect of glucose levels on mortality [30–33]. Our study confirmed that APG scores positively correlated with rates of MACEs in both diabetic and non-diabetic patients.…”

Section: Discussionsupporting

confidence: 73%

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Hao

Lü

et al. 2017

BMC Cardiovasc Disord

View full text Add to dashboard Cite

BackgroundThe association between admission hyperglycemia and adverse outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) has not been well studied, and the optimal plasma glucose cut-off values for prognosis for NSTEMI patients with and without diabetes have not been determined.MethodsAccording to glucose level and diabetes status, consecutive NSTEMI patients undergoing PCI (n = 890) were divided into four groups: without diabetes mellitus (DM) and admission plasma glucose (APG) <144 or ≥144 mg/dL; or with DM and APG <180 or ≥180 mg/dL. All patients were followed up at 30 days and 3 years after discharge, and the outcomes were assessed.ResultsAdmission hyperglycemia was found in 44 and 28% of the DM and non-DM patients, respectively. Multivariable analyses showed that the APG level was an independent predictor of 30-day and 3-year MACEs. Receiver operating characteristic curve analysis revealed that the appropriate cut-off values were 178 and 145 mg/dL for patients with and without DM, respectively, or 157 mg/dL for all patients.ConclusionsAdmission hyperglycemia may be used to predict 30-day and 3-year MACEs in patients with NSTEMI undergoing PCI, irrespective of diabetes status. However, the optimal admission glucose cut-off values for predicting prognosis differ for patients with or without DM.

show abstract

Section: Discussionsupporting

confidence: 73%

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Hao

Lü

et al. 2017

BMC Cardiovasc Disord

View full text Add to dashboard Cite

show abstract

“…In our study we also presented the incidence of newonset AF in STEMI patients according to the reperfusion regimens. In accordance with a recently published study, there were no significant differences in the development of newonset AF according to the reperfusion regimens (primary PCI vs thrombolysis) 26,27 .…”

Section: Discussionsupporting

confidence: 91%

Predictors and outcomes of new-onset atrial fibrillation in patients with acute myocardial infarction

Vukmirović

Bošković

Bukumirić³

et al. 2017

VOJNOSANIT PREGL

View full text Add to dashboard Cite

Background/Aim. The onset of atrial fibrillation (AF) in the acute phase of myocardial infarction (MI) may be a predictor of poor prognosis. The aim of our study was to examine this relationship. Methods. Six hundred patients were enrolled in the study and divided into two groups. The first group included 48 patients with new-onset AF and the second group of 552 patients without this arrhythmia. Patients with previously registered AF were excluded from the study. We investigated the correlation between new-onset AF and intra-hospital mortality as well as mortality during the follow-up period of 48 months. We also analyzed predictors of this arrhythmia. Results. Newonset AF was registered in 48 (8%) patients. The independent predictors of this arrhythmia were older age, particularly more than 70 years [odds ratio 2.37; 95% confidence interval (CI) 1.23-4.58) and increased body mass index (odds ratio 1.17; 95% CI 1.04-1.33). Patients with new-onset AF had a higher mortality during the hospital course than patients without AF, but this difference was not statistically significant (10.4% vs 5.6%, p = 0.179). Patients with this arrhythmia had also a higher mortality after follow-up period of 48 months than patients without AF (33.3 % vs 17.8%, p = 0.009). Major adverse cardiac and cardiovascular events (MACCE) defined as death, recurrent MI, revascularization, and stroke were more after registered in patients with new-onset AF than in those with no this arrhythmia after follow-up period of 48 months (52.1% vs 33.9%, p = 0.011). However, multivariate Cox's regression analysis demonstrated that new-onset AF was not an independent predictor of mortality during the follow-up period of 48 months (HR 0.68; 95% CI 0.38-1.20; p = 0.182). Conclusion. New-onset AF in patients with MI was associated with a higher mortality as well as MACCE after the follow-up period of 48 months but was not an independent predictor of mortality during this period.

show abstract

“…Due to an increase in heart rate, which is usually present in AF, it may worsen ischemia in patients with acute coronary syndrome. Thus, it is not surprising that AF has (at least in the short term) prognostic significance in acute myocardial infarction [1,4] and acute heart failure [5] .…”

mentioning

confidence: 99%

Is Atrial Fibrillation a Prognosticator in Acute Pulmonary Thromboembolism?

Koraćević

Atanaskovic

2010

Med Princ Pract

View full text Add to dashboard Cite

Association of stress hyperglycemia and atrial fibrillation in myocardial infarction

Cited by 27 publications

References 18 publications

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Predictors and outcomes of new-onset atrial fibrillation in patients with acute myocardial infarction

Is Atrial Fibrillation a Prognosticator in Acute Pulmonary Thromboembolism?

Contact Info

Product

Resources

About